Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien S Bonert

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|October 24, 2007
Is long-acting repeatable octreotide an effective primary therapy for patients with acromegaly?Vivien S Bonert
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenomaVivien S Bonert, Shlomo Melmed
Reviews in Endocrine & Metabolic Disorders|December 29, 2007
Medical therapy: options and usesJohn D Carmichael, Vivien S Bonert
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiencyVivien S Bonert, Janet D Elashoff, Philip Barnett, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2008
The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegalyJohn D Carmichael, Vivien S Bonert, James M Mirocha, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysisJohn D Carmichael, Vivien S Bonert, Miriam Nuño, et al.
BMC Endocrine Disorders|May 19, 2010
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomasBeverly Mk Biller, Annamaria Colao, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2008
Lipodystrophy in patients with acromegaly receiving pegvisomantVivien S Bonert, Laurence Kennedy, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2014
A structural and functional acromegaly classificationDaniel Cuevas-Ramos, John D Carmichael, Odelia Cooper, et al.
Journal of Neurosurgery|November 8, 2014
Hyperprolactinemia due to spontaneous intracranial hypotensionWouter I Schievink, Miriam Nuño, Todd D Rozen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Endocrinology & Metabolism|October 24, 2007
Is long-acting repeatable octreotide an effective primary therapy for patients with acromegaly?Vivien S Bonert
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenomaVivien S Bonert, Shlomo Melmed
Reviews in Endocrine & Metabolic Disorders|December 29, 2007
Medical therapy: options and usesJohn D Carmichael, Vivien S Bonert
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiencyVivien S Bonert, Janet D Elashoff, Philip Barnett, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2008
The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegalyJohn D Carmichael, Vivien S Bonert, James M Mirocha, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysisJohn D Carmichael, Vivien S Bonert, Miriam Nuño, et al.
BMC Endocrine Disorders|May 19, 2010
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomasBeverly Mk Biller, Annamaria Colao, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2008
Lipodystrophy in patients with acromegaly receiving pegvisomantVivien S Bonert, Laurence Kennedy, Stephan Petersenn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2014
A structural and functional acromegaly classificationDaniel Cuevas-Ramos, John D Carmichael, Odelia Cooper, et al.
Journal of Neurosurgery|November 8, 2014
Hyperprolactinemia due to spontaneous intracranial hypotensionWouter I Schievink, Miriam Nuño, Todd D Rozen, et al.
Pageof 2